Vaccine Liability Question Is Urgent, Gov't. Says; Supreme Court Takes Up Case
Executive Summary
At the encouragement of the government, the U.S. Supreme Court agreed to take up the question of whether a federal law shields vaccine manufacturers from all liability for alleged vaccine design defects
You may also be interested in...
High Court’s Vaccines Ruling Gives Drug Makers Hope For Design Defect Claim Pre-emption
The U.S. Supreme Court’s ruling that vaccine design defect claims are statutorily pre-empted could provide a potential defense in certain pharmaceutical product liability lawsuits, industry attorneys said.
High Court’s Vaccines Ruling Gives Drug Makers Hope For Design Defect Claim Pre-emption
The U.S. Supreme Court’s ruling that vaccine design defect claims are statutorily pre-empted could provide a potential defense in certain pharmaceutical product liability lawsuits, industry attorneys said.
Supreme Court Immunizes Vaccine Manufacturers Against Design Defect Claims
In a 6-2 decision, the high court rules that manufacturers need not show that it would have been impossible to make a safer product and that plaintiffs' injuries were, therefore, unavoidable.